A bibliometric analysis of atezolizumab in hepatocellular carcinoma

Abstract Background Hepatocellular carcinoma (HCC) is a highly prevalent primary liver cancer, accounting for over 90% of all liver cancer cases worldwide and ranking as the third leading cause of cancer-related deaths. The emergence of molecular targeted therapies has completely transformed the tre...

Full description

Bibliographic Details
Published in:Discover Oncology
Main Authors: Yuqing Xu, Hucheng Zhang, Haipeng Yu
Format: Article
Language:English
Published: Springer 2025-10-01
Subjects:
Atezolizumab
Hepatocellular carcinoma
Bibliometrics
Data mining
Online Access:https://doi.org/10.1007/s12672-025-03447-6

Internet

https://doi.org/10.1007/s12672-025-03447-6

Similar Items